MovDisordV3, PubMed, Curation, bibRecord, 003981

DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.

Identifieur interne : 003981 ( PubMed/Curation ); précédent : 003980; suivant : 003982

DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.

Auteurs :

Source :

Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2002.

RBID : pubmed:12211144

English descriptors

KwdEn :
- Dopamine Agonists (adverse effects), Dopamine Agonists (pharmacology), Dopamine Agonists (therapeutic use), Drug Therapy, Combination, Ergot Alkaloids (adverse effects), Ergot Alkaloids (pharmacology), Ergot Alkaloids (therapeutic use), Humans, Levodopa (therapeutic use), Lisuride (adverse effects), Lisuride (pharmacology), Lisuride (therapeutic use), Parkinson Disease (drug therapy), Psychomotor Disorders (prevention & control), Randomized Controlled Trials as Topic.
MESH :
- chemical , adverse effects : Dopamine Agonists, Ergot Alkaloids, Lisuride.
- chemical , pharmacology : Dopamine Agonists, Ergot Alkaloids, Lisuride.
- chemical , therapeutic use : Dopamine Agonists, Ergot Alkaloids, Levodopa, Lisuride.
- drug therapy : Parkinson Disease.
- prevention & control : Psychomotor Disorders.
- Drug Therapy, Combination, Humans, Randomized Controlled Trials as Topic.

DOI: 10.1002/mds.5565
PubMed: 12211144

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003981

Links to Exploration step

pubmed:12211144

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:12211144</idno>
<idno type="pmid">12211144</idno>
<idno type="doi">10.1002/mds.5565</idno>
<idno type="wicri:Area/PubMed/Corpus">003981</idno>
<idno type="wicri:Area/PubMed/Curation">003981</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.</title>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dopamine Agonists (adverse effects)</term>
<term>Dopamine Agonists (pharmacology)</term>
<term>Dopamine Agonists (therapeutic use)</term>
<term>Drug Therapy, Combination</term>
<term>Ergot Alkaloids (adverse effects)</term>
<term>Ergot Alkaloids (pharmacology)</term>
<term>Ergot Alkaloids (therapeutic use)</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Lisuride (adverse effects)</term>
<term>Lisuride (pharmacology)</term>
<term>Lisuride (therapeutic use)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Psychomotor Disorders (prevention & control)</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Dopamine Agonists</term>
<term>Ergot Alkaloids</term>
<term>Lisuride</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Dopamine Agonists</term>
<term>Ergot Alkaloids</term>
<term>Lisuride</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Dopamine Agonists</term>
<term>Ergot Alkaloids</term>
<term>Levodopa</term>
<term>Lisuride</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Psychomotor Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">12211144</PMID>
<DateCreated><Year>2002</Year>
<Month>09</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted><Year>2002</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>17 Suppl 4</Volume>
<PubDate><Year>2002</Year>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>S74-8</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018491">Dopamine Agonists</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004876">Ergot Alkaloids</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>46627O600J</RegistryNumber>
<NameOfSubstance UI="D007980">Levodopa</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>E0QN3D755O</RegistryNumber>
<NameOfSubstance UI="D008090">Lisuride</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D018491">Dopamine Agonists</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004359">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004876">Ergot Alkaloids</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007980">Levodopa</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008090">Lisuride</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011596">Psychomotor Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016032">Randomized Controlled Trials as Topic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>15</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year>
<Month>9</Month>
<Day>5</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2002</Year>
<Month>11</Month>
<Day>26</Day>
<Hour>4</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2002</Year>
<Month>9</Month>
<Day>5</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">12211144</ArticleId>
<ArticleId IdType="doi">10.1002/mds.5565</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003981 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003981 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:12211144
   |texte=   DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:12211144" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.

DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki